Cocrystal Share Price
NASDAQ: COCP | Micro Cap | HealthcareCocrystal Stock Performance
Cocrystal Share Price Chart
Cocrystal Quarterly Profit & Loss
All figures in USD
Cocrystal Annual Profit & Loss
All figures in USD
Cocrystal Balance Sheet
All figures in USD Million
Cocrystal Cash Flow
All figures in USD Million
Corporate Actions
About Cocrystal
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
Cocrystal Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.09 | $0.93 | -4.62% |
Oct 2026 | $1.14 | $0.97 | -13.33% |
Sep 2026 | $1.14 | $1.13 | -2.17% |
Aug 2026 | $0.96 | $1.15 | +32.64% |
Jul 2026 | $1.06 | $0.87 | -17.03% |
Jun 2026 | $1.14 | $1.04 | -5.00% |
May 2026 | $1.41 | $1.10 | -23.08% |
Apr 2026 | $1.03 | $1.43 | +43.00% |
Mar 2026 | $1.02 | $1.00 | -4.76% |
Feb 2026 | $0.98 | $1.05 | +6.06% |
Jan 2026 | $0.99 | $0.99 | +2.06% |
Dec 2025 | $1.04 | $0.97 | +4.19% |